+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Urokinase Market by Type (Urokinase Powder, Urokinase Solution), Dose Strength (250000 Unit, 5000 Unit), Indication, Application - Forecast 2024-2030- Product Image
Global Urokinase Market by Type (Urokinase Powder, Urokinase Solution), Dose Strength (250000 Unit, 5000 Unit), Indication, Application - Forecast 2024-2030- Product Image
Sale

Global Urokinase Market by Type (Urokinase Powder, Urokinase Solution), Dose Strength (250000 Unit, 5000 Unit), Indication, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995126
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Urokinase Market size was estimated at USD 1.76 billion in 2023, USD 1.85 billion in 2024, and is expected to grow at a CAGR of 5.30% to reach USD 2.52 billion by 2030.

Urokinase is a type of enzyme, specifically a serine protease, produced in the kidneys and found in the urine. Urokinase plays a crucial role in the body's process of breaking down blood clots, making it an essential therapeutic agent in treating severe or life-threatening blood clotting conditions such as pulmonary embolism, coronary artery thrombosis, and certain types of stroke. The increased prevalence of these cardiovascular diseases and stroke globally has significantly expanded the use of urokinase as an effective treatment option. This trend is driven by an aging population, lifestyle factors, and the rising incidence of obesity, all of which contribute to the higher occurrence of thrombotic conditions.

However, patients may experience side effects such as bleeding, allergic reactions, and other potential risks. However, the market for urokinase presents several opportunities for growth and expansion. Advances in biotechnology may lead to the production of more efficient and safer forms of urokinase, expanding its use into new therapeutic areas. Additionally, the increasing global healthcare expenditure and a better understanding of the conditions treated with urokinase are expected to further drive demand. There is also potential for developing novel drug delivery systems that could enhance the effectiveness and ease of use of urokinase-based treatments, thereby improving patient outcomes. As such, the urokinase market is positioned for sustained growth fueled by technological advancements, increased disease prevalence, and ongoing research efforts.

Regional Insights

The Urokinase market in the Americas, notably the United States, shows significant growth potential due to the high prevalence of cardiovascular diseases and lifestyle-related conditions that lead to thrombosis. Advanced healthcare infrastructure, coupled with substantial investments in research and development, supports market expansion in this region. In the EMEA region, Europe stands out as a significant market for Urokinase due to its well-established healthcare system and an increasing patient pool requiring thrombolytic therapy. Initiatives for stroke prevention and awareness about the treatments available for thrombosis are factors propelling the market forward.

The Middle East and Africa, while emerging markets, show promise due to government initiatives to improve healthcare infrastructure and increase healthcare spending. The Asia Pacific region is projected to be the fastest-growing market for Urokinase, driven by rapidly developing healthcare systems, increased healthcare expenditures, and a rising prevalence of diseases associated with blood clots. Countries, including China and India, are at the forefront, with China being a significant player due to its large-scale production and favorable government policies for biopharmaceuticals. Increasing awareness about thrombotic diseases and their treatments and improvements in healthcare infrastructure contribute to the market’s growth in the region.

Market Trends by Segment

  • Type: Significant preference towards urokinase powder due to superior shelf life
  • Application: Expanding application of urokinase in hospitals as a pivotal therapeutic agent

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Strategic Alliance Revives Kinlytic: A Milestone in Thrombolytic Therapy

Microbix Biosystems Inc., in collaboration with Sequel Pharma, LLC, reinforced its commitment to bring Kinlytic® urokinase, a vital thrombolytic medication, back to the US market, focusing initially on treating venous catheter blockages. This agreement aims to meet Microbix’s foundational vision, anticipating Kinlytic's substantial benefit to patients and its contribution to the company’s financial growth.

Key Company Profiles

The report delves into recent significant developments in the Urokinase Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BBT Biotech GmbH, Cerbios-Pharma SA, Echelon Biosciences, Ilex Life Sciences LLC, JCR Pharmaceuticals Co., Ltd., Jiangsu Aidea Pharmaceutical Co., Ltd, Jiangxi Haoran Bio-pharma Co., Ltd., Kraeber & Co GmbH, Merck KGaA, Microbix Biosystems Inc., Midas Pharma GmbH, Pfizer Inc., Syner-Med Pharmaceuticals, Taj Pharmaceuticals Ltd., Thermo Fisher Scientific Inc., VWR International, LLC, Wanhua Biochem Products Co. Ltd., and Zydus Lifesciences Limited.

This research report offers invaluable insights into various crucial aspects of the Urokinase Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of pulmonary embolism and coronary artery thrombosis worldwide=
5.1.1.2. Supportive government approvals for urokinase-based medications
5.1.2. Restraints
5.1.2.1. High costs of drug development and availability of alternatives
5.1.3. Opportunities
5.1.3.1. Ongoing research and development to improve the applicability of urokinase
5.1.3.2. Adoption of advanced drug delivery systems to enhance the effectiveness of urokinase-based treatments
5.1.4. Challenges
5.1.4.1. Side effects associated with urokinase-based drugs
5.2. Market Segmentation Analysis
5.2.1. Type: Significant preference towards urokinase powder due to superior shelf life
5.2.2. Application: Expanding application of urokinase in hospitals as a pivotal therapeutic agent
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Urokinase Market, by Type
6.1. Introduction
6.2. Urokinase Powder
6.3. Urokinase Solution
7. Urokinase Market, by Dose Strength
7.1. Introduction
7.2. 250000 Unit
7.3. 5000 Unit
8. Urokinase Market, by Indication
8.1. Introduction
8.2. Catheter Clearance
8.3. Coronary Artery Thrombosis
8.4. Deep Vein Thrombosis
8.5. Pulmonary Embolism
9. Urokinase Market, by Application
9.1. Introduction
9.2. Hospital
9.3. Research Institutions
9.4. Specialty Clinics
10. Americas Urokinase Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Urokinase Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Urokinase Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Strategic Alliance Revives Kinlytic: A Milestone in Thrombolytic Therapy
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. UROKINASE MARKET RESEARCH PROCESS
FIGURE 2. UROKINASE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL UROKINASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. UROKINASE MARKET DYNAMICS
FIGURE 7. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2023 VS 2030 (%)
FIGURE 10. GLOBAL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL UROKINASE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL UROKINASE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. UROKINASE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. UROKINASE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. UROKINASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL UROKINASE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL UROKINASE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL UROKINASE MARKET SIZE, BY 250000 UNIT, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL UROKINASE MARKET SIZE, BY 250000 UNIT, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL UROKINASE MARKET SIZE, BY 5000 UNIT, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL UROKINASE MARKET SIZE, BY 5000 UNIT, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL UROKINASE MARKET SIZE, BY CATHETER CLEARANCE, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL UROKINASE MARKET SIZE, BY CATHETER CLEARANCE, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL UROKINASE MARKET SIZE, BY CORONARY ARTERY THROMBOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL UROKINASE MARKET SIZE, BY CORONARY ARTERY THROMBOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL UROKINASE MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL UROKINASE MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL UROKINASE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL UROKINASE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL UROKINASE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL UROKINASE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL UROKINASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL UROKINASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. CANADA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. CANADA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. CANADA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 66. CANADA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 67. CANADA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 68. CANADA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 69. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. MEXICO UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 72. MEXICO UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 73. MEXICO UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 74. MEXICO UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 75. MEXICO UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 76. MEXICO UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 77. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. CHINA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. CHINA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. CHINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 110. CHINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 111. CHINA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 112. CHINA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 113. CHINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. CHINA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. INDIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. INDIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. INDIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 118. INDIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 119. INDIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 120. INDIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 121. INDIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. INDIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. JAPAN UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. JAPAN UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. JAPAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 134. JAPAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 135. JAPAN UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 136. JAPAN UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 137. JAPAN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. JAPAN UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. THAILAND UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. THAILAND UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. THAILAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 182. THAILAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 183. THAILAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 184. THAILAND UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 185. THAILAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. THAILAND UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 205. DENMARK UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. DENMARK UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. DENMARK UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 208. DENMARK UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 209. DENMARK UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 210. DENMARK UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 211. DENMARK UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. DENMARK UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. EGYPT UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. EGYPT UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. EGYPT UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 216. EGYPT UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 217. EGYPT UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 218. EGYPT UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 219. EGYPT UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. EGYPT UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. FINLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. FINLAND UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. FINLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 224. FINLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 225. FINLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 226. FINLAND UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 227. FINLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. FINLAND UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. FRANCE UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 230. FRANCE UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231. FRANCE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 232. FRANCE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 233. FRANCE UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. FRANCE UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. GERMANY UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. GERMANY UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. GERMANY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 240. GERMANY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 241. GERMANY UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 242. GERMANY UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 243. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. ITALY UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. ITALY UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. ITALY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 256. ITALY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 257. ITALY UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 258. ITALY UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 259. ITALY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. ITALY UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. NORWAY UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. NORWAY UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. NORWAY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 280. NORWAY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 281. NORWAY UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 282. NORWAY UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 283. NORWAY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. NORWAY UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. POLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 286. POLAND UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287. POLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 288. POLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 289. POLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 290. POLAND UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 291. POLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. POLAND UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. QATAR UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 294. QATAR UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 295. QATAR UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 296. QATAR UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 297. QATAR UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 298. QATAR UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 299. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 325. SPAIN UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 326. SPAIN UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 327. SPAIN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 328. SPAIN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 329. SPAIN UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 330. SPAIN UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 331. SPAIN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 332. SPAIN UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 349. TURKEY UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 350. TURKEY UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 351. TURKEY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 352. TURKEY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 353. TURKEY UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 354. TURKEY UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 355. TURKEY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 356. TURKEY UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 366. UNITED KINGDOM UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
TABLE 368. UNITED KINGDOM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
TABLE 369. UNITED KINGDOM UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 370. UNITED KINGDOM UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 371. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 372. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 373. UROKINASE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 374. UROKINASE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abbott Laboratories
  • BBT Biotech GmbH
  • Cerbios-Pharma SA
  • Echelon Biosciences
  • Ilex Life Sciences LLC
  • JCR Pharmaceuticals Co., Ltd.
  • Jiangsu Aidea Pharmaceutical Co., Ltd
  • Jiangxi Haoran Bio-pharma Co., Ltd.
  • Kraeber & Co GmbH
  • Merck KGaA
  • Microbix Biosystems Inc.
  • Midas Pharma GmbH
  • Pfizer Inc.
  • Syner-Med Pharmaceuticals
  • Taj Pharmaceuticals Ltd.
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC
  • Wanhua Biochem Products Co. Ltd.
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.85 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.52 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And Anticoagulants Type, By Application, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And Anticoagulants Type, By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2023-2028 - Product Image

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2023-2028

  • Report
  • 146 Pages
  • Global
From
Global Cardiovascular Drugs Market by Drug Type (Angiotensin Inhibitors, Anticoagulants, Antihyperlipidemic), Disease Indication (Arrhythmia, Coronary Artery Disease, Hyperlipidaemia), Route of Administration, Mode of Purchase, End-Users - Forecast 2024-2030 - Product Image

Global Cardiovascular Drugs Market by Drug Type (Angiotensin Inhibitors, Anticoagulants, Antihyperlipidemic), Disease Indication (Arrhythmia, Coronary Artery Disease, Hyperlipidaemia), Route of Administration, Mode of Purchase, End-Users - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Global Anti-Ischemic Agents Market by Type (Antiplatelet Agents, Calcium Channel Blockers, Organic Nitrates), Indication (Angina Pectoris, Ischemic Stroke, Myocardial Infarction), Route of Administration, End-User - Forecast 2024-2030 - Product Image

Global Anti-Ischemic Agents Market by Type (Antiplatelet Agents, Calcium Channel Blockers, Organic Nitrates), Indication (Angina Pectoris, Ischemic Stroke, Myocardial Infarction), Route of Administration, End-User - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Global Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030 - Product Image

Global Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030

  • Report
  • 175 Pages
  • Global
From

About the Urokinase Market

Urokinase is a type of cardiovascular drug used to treat a variety of conditions, including pulmonary embolism, deep vein thrombosis, and acute myocardial infarction. It is a thrombolytic agent, meaning it works by breaking down blood clots and restoring blood flow to the affected area. Urokinase is administered intravenously and is typically used in combination with other medications. It is also used to prevent the formation of new blood clots. Urokinase is a widely used drug in the cardiovascular market, with a variety of manufacturers offering it in different forms. It is available in both generic and branded versions, with the latter being more expensive. The drug is also available in different concentrations, depending on the patient's needs. Some of the companies in the Urokinase market include Pfizer, Sanofi, Merck, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.